Antiverse Secures £7M for AI-Driven Drug Design

Antiverse, a Cardiff-based AI life sciences company, secures £7 million in Series A funding from Development Bank of Wales, Cardiff Capital Region, and international backers. The investment will support intellectual property development and team growth, positioning Antiverse for global expansion in oncology, immunology, and infectious diseases. Support the showGet a discount at https://solipillow.com/discount/dnn. Advertise on [email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected] View sources & latest updateshttps://sources.thednn.ai/14736b577705b711